The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
August 15th 2025
Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.
Australian Study Emphasizes Importance of Balanced Healthcare Reporting
June 15th 2015A study published in the Medical Journal of Australia found that a TV program questioning the link between statin use and cholesterol reduction resulted in more than 60,000 Australians reducing or discontinuing the medication.
Read More
A Third of the World's Population Has More Than 5 Health Problems
June 14th 2015With a growing world population and a growing proportion of elderly, more people are living in suboptimal health around the world. A third of the world's population experienced more than 5 ailments in 2013, according to a study published in The Lancet.
Read More
With more patients surviving cancer comes more effort to ensure that treatment itself does not shorten life, especially by damaging the heart. A special issue of Evidence-Based Oncology that takes a look at the growing specialty of cardio-oncology starts with a feature on the program at Massachusetts General Hospital.
Read More
Proposed Center Within FDA Could Streamline Approval Process for Lab-Developed Tests
June 12th 2015The House Energy and Commerce Committee is drafting language that will help create an in vitro center within the FDA to define risk categories for laboratory-developed tests (LDTs), and set timelines to accelerate the approval process for LDTs.
Read More
Physician Characteristic Strongest Predictor of Hospice Use Among Patients
June 11th 2015There was a strong connection between the proportion of patients a physician already had enrolled in hospice care and whether or not other patients would enroll in hospice, according to a study published in Health Affairs.
Read More
Experimental Treatment for Diabetic Kidney Disease Based on Precision Medicine
June 11th 2015The drug, baricitinib, is a JAK-STAT inhibitor being developed for rheumatoid arthritis. Research by scientists at the Unviersity of Michigan found a key role for the pathway in diabetic patients suffering from kidney disease.
Read More